334 related articles for article (PubMed ID: 2535919)
1. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.
Hällgren R; Colombel JF; Dahl R; Fredens K; Kruse A; Jacobsen NO; Venge P; Rambaud JC
Am J Med; 1989 Jan; 86(1):56-64. PubMed ID: 2535919
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil and eosinophil involvement of the small bowel affected by chronic alcoholism.
Colombel JF; Hällgren R; Venge P; Mesnard B; Rambaud JC
Gut; 1988 Dec; 29(12):1656-60. PubMed ID: 2851504
[TBL] [Abstract][Full Text] [Related]
3. Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease.
Lavö B; Knutson L; Lööf L; Odlind B; Venge P; Hällgren R
Am J Med; 1989 Dec; 87(6):655-60. PubMed ID: 2589401
[TBL] [Abstract][Full Text] [Related]
4. Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein.
Colombel JF; Torpier G; Janin A; Klein O; Cortot A; Capron M
Gut; 1992 Sep; 33(9):1190-4. PubMed ID: 1427370
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.
Raab Y; Fredens K; Gerdin B; Hällgren R
Dig Dis Sci; 1998 May; 43(5):1061-70. PubMed ID: 9590423
[TBL] [Abstract][Full Text] [Related]
6. Secretion and tissue content of eosinophil cationic protein in Crohn's disease.
Winterkamp S; Raithel M; Hahn EG
J Clin Gastroenterol; 2000 Mar; 30(2):170-5. PubMed ID: 10730922
[TBL] [Abstract][Full Text] [Related]
7. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
[TBL] [Abstract][Full Text] [Related]
8. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariae and schistosomes.
Tischendorf FW; Brattig NW; Büttner DW; Pieper A; Lintzel M
Acta Trop; 1996 Dec; 62(3):171-82. PubMed ID: 9025985
[TBL] [Abstract][Full Text] [Related]
10. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease.
Peterson CG; Eklund E; Taha Y; Raab Y; Carlson M
Am J Gastroenterol; 2002 Jul; 97(7):1755-62. PubMed ID: 12135031
[TBL] [Abstract][Full Text] [Related]
11. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.
Hällgren R; Bjermer L; Lundgren R; Venge P
Am Rev Respir Dis; 1989 Feb; 139(2):373-7. PubMed ID: 2536526
[TBL] [Abstract][Full Text] [Related]
12. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis.
Koller DY; Urbanek R; Götz M
Am J Respir Crit Care Med; 1995 Aug; 152(2):629-33. PubMed ID: 7633718
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.
Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y
Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil activation in the lung is related to lung damage in adult respiratory distress syndrome.
Hällgren R; Samuelsson T; Venge P; Modig J
Am Rev Respir Dis; 1987 Mar; 135(3):639-42. PubMed ID: 3030169
[TBL] [Abstract][Full Text] [Related]
15. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma.
Carlson M; Håkansson L; Peterson C; Stålenheim G; Venge P
J Allergy Clin Immunol; 1991 Jan; 87(1 Pt 1):27-33. PubMed ID: 1846890
[TBL] [Abstract][Full Text] [Related]
16. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction.
Ott NL; Gleich GJ; Peterson EA; Fujisawa T; Sur S; Leiferman KM
J Allergy Clin Immunol; 1994 Jul; 94(1):120-8. PubMed ID: 8027490
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement.
Hällgren R; Bjelle A; Venge P
Ann Rheum Dis; 1984 Aug; 43(4):556-62. PubMed ID: 6236759
[TBL] [Abstract][Full Text] [Related]
18. Increased fecal eosinophil cationic protein in inflammatory bowel disease.
Berstad A; Børkje B; Riedel B; Elsayed S; Berstad A
Hepatogastroenterology; 1993 Jun; 40(3):276-8. PubMed ID: 8325594
[TBL] [Abstract][Full Text] [Related]
19. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris.
Czech W; Schaller J; Schöpf E; Kapp A
J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):210-5. PubMed ID: 8393016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]